Fundraising Fox

ClavystBio

Venture studio

Singapore · Seed–Series A · 33 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

ClavystBio operates as both a life sciences investor and a venture builder, focusing on creating and scaling global biotech companies. It fosters company creation and growth via active incubation and investment, while forging public and private partnerships and accelerating talent development to drive commercialization within its innovation community.

Invests inBiotechDigital HealthHealthtechLongevityMedical DevicesAsia-PacificGlobalSingaporeSingapore

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
HQ
Singapore, SG
Instruments
Equity
Founded
2022
AUM
$220M
Tracked investments
21

Team · 33 people

from the firm's website & public directories

What they invest in

from 5 of 21 portfolio companies

Biotech ×5Healthtech ×2AI & Machine Learning ×1Deep Tech ×1Medical Devices ×1PropTech ×1

HQs:United States×2Netherlands×1Singapore×1

Investments · 21 tracked

founders shown can be your intro path
Accelerator Life Science Partners (ALSP)
Automera

Early-stage biotech company developing autophagy-based targeted protein degradation therapeutics for cancer and genetic diseases.

Callio Therapeutics

Seattle and Singapore-based biotech developing next-generation multi-payload antibody-drug conjugates for cancer treatment.

Cirrus Therapeutics

Ocular immunology-focused biotech developing cell and gene therapies for age-related macular degeneration and other chronic blinding diseases.

CoVBio

Biotech company developing booster vaccines and therapeutics against SARS-2 beta coronavirus variants.

Droia
Droia Ventures

Specialist biotech investor focusing on precision therapeutics for oncology and genetic disease from newly founded through early clinical-stage.

Engine Biosciences

Singapore and US-based precision medicine biotech using machine learning and experimental biology to develop cancer and disease therapies.

Eyexora

Global ophthalmology company using a hub-and-spoke model to develop a diversified pipeline of eye care therapies and devices.

Hummingbird Biosciencehummingbirdbioscience.comin𝕏

Hummingbird Bioscience develops antibody-based therapeutics, including antibody-drug conjugates (ADCs), using proprietary linker-payload and biologics discovery platforms.

BiotechHealthtech

Leyden Labsleydenlabs.comin

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses at the nasal mucosa to prevent initial infection and transmission.

BiotechHealthtechMedical DevicesLeiden, NL

Koenraad Wiedhaup(Founder and Chief Executive Officer)inRonald Brus(Founder and Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)in

Lightstone Ventures

Global venture capital firm investing in early-stage and opportunistic late-stage therapeutic and life science companies.

MediSix Therapeutics

Singapore-based immune engineering company developing novel cellular therapies for T-cell malignancies and autoimmune diseases.

NSG Bionsgbio.comin

NSG Bio operates BSL-2 certified co-working wet-laboratory and office spaces for life sciences and biotech companies in Singapore, offering turnkey facilities, shared equipment, and support services for startups and multinationals conducting R&D.

BiotechPropTechSingapore, SG

Nuevocornuevocor.comin
Paratus Sciencesparatussciences.comin

Paratus Sciences develops first-in-class medicines for cardiometabolic and immune & inflammatory diseases by leveraging evolutionary biology and AI to identify novel drug targets.

AI & Machine LearningBiotechDeep TechUnited States, US

Polaris Partners

Global venture capital firm investing in disruptive healthcare and technology companies through active partnership and mentorship.

Quilt

Generative AI-powered digital health platform providing personalized interventions for stress, anxiety, insomnia, and mental health challenges.

Rejonirejoni.cominSep 2020

Hydrogel product to prevent intrauterine adhesions after uterine surgery

BiotechBedford, US

AMARPREET SAWHNEY(Executive Officer, Director, Promoter)NICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)

BoardTARA BUTLER(Executive Officer, Director, Promoter)

Remiges Ventures

Venture capital firm with offices in Japan and the United States focusing on company creation based on innovative science and early-stage products.

Respiree

AI/ML health tech company building clinically-validated artificial intelligence for measuring and tracking disease progression across healthcare settings.

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does ClavystBio invest at?
ClavystBio invests at the Seed, Series A stages.
What sectors does ClavystBio focus on?
ClavystBio focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
Where is ClavystBio located?
ClavystBio is headquartered in Singapore, SG.

Images

ClavystBio photo

Similar investors

Featured in lists